iifl-logo

Mankind Pharma Ltd Historical Data

2,557.5
(-1.60%)
Apr 25, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mankind Pharma Ltd Historical Data

25/03/2025calendar-icon
25/04/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

26-Mar-2025

2,415

2,4422,361.42,403.739,11584,05,05,745.41,79,869

27-Mar-2025

2,402.75

2,492.72,372.52,452.1546,9321,34,19,20,995.453,65,275

28-Mar-2025

2,467.95

2,4852,411.052,424.7550,4691,17,01,63,234.353,28,705

01-Apr-2025

2,423.5

2,468.952,397.42,458.135,0681,22,40,73,515.053,31,434

02-Apr-2025

2,458.1

2,470.452,4032,421.926,40243,83,35,782.4590,096

03-Apr-2025

2,463

2,5302,415.452,427.742,5281,09,33,22,731.051,71,752

04-Apr-2025

2,429

2,463.452,4052,451.242,89795,64,02,625.151,72,451

07-Apr-2025

2,362

2,4442,332.052,383.4567,2862,11,77,76,929.84,69,170

08-Apr-2025

2,408.85

2,453.052,335.22,347.559,1441,25,28,55,163.33,02,085

09-Apr-2025

2,337

2,3372,292.752,313.9539,5581,30,97,67,016.34,26,796

11-Apr-2025

2,369

2,384.952,3162,350.524,57170,20,46,133.61,60,471

15-Apr-2025

2,420

2,458.92,3912,426.147,69187,66,11,187.32,23,020

16-Apr-2025

2,425

2,538.12,418.12,52059,8411,91,13,69,052.55,27,921

17-Apr-2025

2,509.9

2,6002,5002,581.639,8201,25,61,73,639.82,94,335

21-Apr-2025

2,586.3

2,609.22,554.52,588.417,23588,46,92,110.32,35,153

22-Apr-2025

2,588.4

2,613.82,554.12,579.526,5521,18,80,01,857.23,49,877

23-Apr-2025

2,580

2,586.42,521.72,545.530,6961,06,42,01,654.22,81,356

24-Apr-2025

2,546.6

2,6292,5352,599.233,66397,80,55,583.62,11,545

Mankind Pharma: Related NEWS

Mankind Pharma Faces ₹183.11 Crore Tax Demand
30 Mar 2025|04:34 PM

The cumulative demand, including interest charges, is ₹183.11 crore.

Read More
Mankind Pharma Merges Three Subsidiaries
30 Mar 2025|01:33 PM

The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.

Read More
Mankind Pharma Faces ₹111.68 Crore Tax Demand, Plans to Appeal
28 Feb 2025|11:13 PM

The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.

Read More
Top Stocks for Today - 24th January 2025
24 Jan 2025|07:50 AM

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%
23 Jan 2025|11:57 PM

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV
8 Jan 2025|04:01 PM

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

Read More
Mankind Pharma, Innovent Join Forces for Cancer Care
26 Dec 2024|12:46 PM

According to the National Cancer Registry Programme, cancer is expected to cause 29.8 million DALYs by 2025, making it a serious health issue in India.

Read More
Mankind Pharma Secures ₹3,000 Crore via QIP for Growth
20 Dec 2024|02:06 PM

The issue price includes a premium of ₹2,519 per share, aggregating a total of ₹2,999.99 crore.

Read More
Mankind Pharma Sees 30% Profit Surge in Q2
6 Nov 2024|10:12 PM

Revenue from operations grew by 13.6% YoY, totaling ₹3,076.5 Crore, up from ₹2,708.1 Crore in Q2 of the previous fiscal.

Read More
Top stocks for today - 6th November 2024
6 Nov 2024|08:08 AM

Here are some of the stocks that may see significant price movement today: Dr Reddy’s, Hindustan Zinc, Titan Company, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.